What this is
- How it works
- How it works isn't classified yet
- Tested for
- Center Involved Diabetic Macular Edema, Diabetic Macular Edema
- Main trialPhase 1
- “A Phase 1 study to assess the safety and efficacy of OCU200 for center-involved diabetic macular edema”In the company’s words, NCT05802329 on ClinicalTrials.gov
Other drugs for Diabetic Macular Edema
Coming up0
No dates coming up.
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials1
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 1Recruiting | 31 Jul 2026 | Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME) |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026